Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial
Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial
نویسندگان: حمید طیبی خسروشاهی , بهزاد عابدی , بهلول حبیبی اصل , مرتضی قوجازاده , امیرمنصور وطن خواه
کلمات کلیدی: End stage renal disease, hemodialysis, high maize resistant starch2, inflammatory
marker, oxidative markers
نشریه: 13621 , 8 , 18 , 2018
| نویسنده ثبت کننده مقاله |
حمید طیبی خسروشاهی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کلیه |
| کد مقاله |
64407 |
| عنوان فارسی مقاله |
Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial |
| عنوان لاتین مقاله |
Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
Hemodialysis International |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis
of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated
that consumption of a diet enriched with amylose (HAM-RS2), attenuates oxidative stress and
inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to
explore the effect of dietary amylose supplementation in hemodialysis patients.
Methods: Forty-six stable hemodialysis patients were randomized to receive biscuits containing
20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM-RS2 or
wheat-flour. Fasting predialysis blood samples obtained before, during and at the end of trial were
processed for biomarkers of oxidative stress and inflammation.
Findings: There was no significant difference in baseline clinical or biochemical parameters
between the two groups. Serum levels of TNF-a, IL-6, and malondialdehyde declined significantly
(P< 0.05) in the HAM-RS2-treated group but remained unchanged in the placebo-treated group. No
significant difference was observed in serum Interleukin-1b (IL-1b) and hs-CRP concentrations and
total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly
declined and severity of constipation improved in HAM-RS2-treated patients (P< 0.05). HAMRS2
consumption was well tolerated and did not cause discernible side effects.
Discussion: Administration of HAM-RS2 for eight weeks significantly reduced levels of inflammatory
and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM-RS2 supplementation on clinical
outcomes in end stage renal disease population. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 2018.pdf | 1397/08/07 | 252827 | دانلود |